Toggle navigation
Regional
Industry
People
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Contact Us
Biotechnology News
Source:
Google
Biotechnology News
Adaptive Biotechnologies to Report First
Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026 Taiwan News
Posted on 15 April 2026 | 1:05 pm
Spain plants US$200m flag in Boston with
Spain plants US$200m flag in Boston with debut US biotech fund European Biotechnology Magazine
Posted on 15 April 2026 | 12:01 pm
Biotech competitiveness in Europe must
Biotech competitiveness in Europe must translate into faster access for rare disease patients The Parliament Magazine
Posted on 15 April 2026 | 10:51 am
Why Is PDS Biotechnology Stock Gaining
Why Is PDS Biotechnology Stock Gaining Wednesday? - PDS Biotechnology (NASDAQ:PDSB) Benzinga
Posted on 15 April 2026 | 10:14 am
Curative Biotechnology Engages Sterling
Curative Biotechnology Engages Sterling Pharmaceutical to Manufacture Metformin Ophthalmic Therapy National Today
Posted on 15 April 2026 | 9:34 am
Source:
Yahoo
Biotechnology News
Beeline Medicines debuts with BMS-derived
Beeline Medicines debuts with BMS-derived pipeline The Pharma Letter
Posted on 15 April 2026 | 8:09 am
Forlong Biotechnology Announced CMC
Forlong Biotechnology Announced CMC Readiness to Initiate GMP Batch Production to Support Upcoming P pharmiweb.com
Posted on 15 April 2026 | 8:02 am
RBL LLC launches Duracyte, advancing living
RBL LLC launches Duracyte, advancing living pharmacy platform in Houston’s growing biotech hub Rice University
Posted on 15 April 2026 | 6:59 am
PDS Biotechnology announces positive Phase 2
PDS Biotechnology announces positive Phase 2 trial data for PDS01ADC TipRanks
Posted on 15 April 2026 | 6:39 am
Enodia Therapeutics Appoints Dr. Yvonne
Enodia Therapeutics Appoints Dr. Yvonne McGrath as Chief Scientific Officer to Accelerate Upstream Targeted Protein Degradation Platform Business Wire
Posted on 15 April 2026 | 6:00 am
Source:
Bing
Biotechnology News
PDS Biotechnology Announces Promising Phase
PDS Biotechnology Announces Promising Phase 2 Trial Results of PDS01ADC for Treatment of Colorectal Liver Metastases Quiver Quantitative
Posted on 15 April 2026 | 5:51 am
In a 9-patient colon cancer study, PDS drug
In a 9-patient colon cancer study, PDS drug showed 78% response Stock Titan
Posted on 15 April 2026 | 5:45 am
Fifty 1 Labs, Inc. Accelerates Peptide
Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health Weatherford Democrat
Posted on 15 April 2026 | 5:32 am
Fifty 1 Labs, Inc. Accelerates Peptide
Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health Voice of Alexandria
Posted on 15 April 2026 | 5:32 am
Curative lines up U.S. manufacturer for
Curative lines up U.S. manufacturer for planned AMD eye-drop study Stock Titan
Posted on 15 April 2026 | 5:08 am